Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product Recommendations.
Edward A Belongia, Huong Q Nguyen, David L McClure, Nathaniel Lewis, Sascha Ellington, Brendan Flannery, Joshua G Petrie
Published: 202510.1093/cid/ciaf563
Abstract
New influenza vaccine products might be licensed in coming years. Ideally, these vaccines would generate more broadly cross-reactive and longer-lasting protection than those currently licensed. Recommendations for the use of and potential preference…
Preview only. Read the full abstract at the source